电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

LAT 抗体 (pTyr132)

This anti-LAT antibody is a 兔 多克隆 antibody detecting LAT in WB. Suitable for 人.
产品编号 ABIN6735094
发货至: 中国

Quick Overview for LAT 抗体 (pTyr132) (ABIN6735094)

抗原

See all LAT 抗体
LAT (Linker For Activation of T Cells (LAT))

适用

  • 119
  • 49
  • 33
  • 1

宿主

  • 114
  • 10
  • 2
  • 1

克隆类型

  • 114
  • 13
多克隆

标记

  • 76
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This LAT antibody is un-conjugated

应用范围

  • 85
  • 48
  • 39
  • 39
  • 23
  • 22
  • 15
  • 12
  • 9
  • 4
  • 3
  • 1
  • 1
  • 1
Western Blotting (WB)
  • 抗原表位

    • 20
    • 15
    • 15
    • 10
    • 8
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    pTyr132

    特异性

    Human LAT. Mouse (85% homologous) and rat (77%) LAT have not been tested, but are expected to react.

    纯化方法

    Immunoaffinity Chromatography

    免疫原

    Synthetic phosphopeptide derived from a region of human LAT that contains tyrosine 132.
  • 限制

    仅限研究用
  • 状态

    Liquid

    缓冲液

    PBS (without Mg2+, Ca2+), 1 mg/mL BSA (IgG, protease free), pH 7.2, 0.1% sodium azide.

    储存液

    Sodium azide

    注意事项

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    注意事项

    Avoid repeat freeze-thaw cycles.

    储存条件

    4 °C/-20 °C

    储存方法

    Long term: -20°C, Short term: +4°C, Avoid freeze-thaw cycles.
  • 抗原

    LAT (Linker For Activation of T Cells (LAT))

    别名

    LAT1 / LAT

    背景

    Standard Gene Symbol: LAT, Synonyms: LAT, p36-38, Pp36, LAT1

    基因ID

    27040

    UniProt

    O43561

    途径

    TCR Signaling, Fc-epsilon Receptor Signaling Pathway
You are here:
Chat with us!